Clearview Capital has acquired Northwest Cosmetic Laboratories (NCL), a formulator and manufacturer of cosmetic and skin care products. Gary Voigt, Northwest Cosmetic Laboratories’ owner, will remain a significant investor and will be active as a member of the board of directors. The company will continue to be led by its current management team including its CEO, Matt Bryant.
“We are thrilled to be working with Gary, Matt and the entire NCL team,” said Calvin Neider, Managing Partner of Clearview Capital. “NCL has many attractive avenues of growth which we intend to pursue, and we look forward to supporting the company as it seeks to expand into new product categories and markets, both organically and potentially through acquisition.”
Northwest Cosmetic Laboratories is a formulator and manufacturer of cosmetic and skin care products for branded cosmetic and personal care companies. NCL specializes in formulating “physician strength” skincare and prestige cosmetic products, which are growing categories benefitting from new ingredient technologies and shifting consumer preferences for anti-aging and other cosmetic or health benefits. NCL’s products are sold through retail, internet and direct marketing channels. The company is headquartered in Idaho Falls, ID (www.trustncl.com).
“We are very enthusiastic about our new partnership with Clearview,” said Mr. Voigt. “NCL has significant growth opportunities ahead and Clearview Capital has the experience and resources to help us reach the next level while also preserving the culture that has made us successful.”
Clearview Capital was founded in 1999 by Jim Andersen and Cal Neider and is headquartered in Old Greenwich, CT with additional offices in Chicago and Los Angeles (www.ClearviewCap.com). The acquisition of NCL marks Clearview’s third platform investment for its third fund in the last six months and the ninth acquisition for all Clearview Capital funds in the past twelve months.
© 2014 PEPD • Private Equity’s Leading News Magazine • 4-21-14